Geneva Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$16.5M Sell
125,051
-1,925
-2% -$246K 0.28% 75
2017
Q1
$15.8M Sell
126,976
-1,188
-0.9% -$142K 0.28% 80
2016
Q4
$14.8M Buy
128,164
+40,189
+46% +$4.64M 0.29% 76
2016
Q3
$10.4M Buy
87,975
+422
+0.5% +$51.2K 0.2% 87
2016
Q2
$10.6M Sell
87,553
-7,878
-8% -$895K 0.21% 84
2016
Q1
$10.3M Buy
95,431
+2,540
+3% +$263K 0.21% 87
2015
Q4
$9.54M Buy
92,891
+3,321
+4% +$334K 0.18% 94
2015
Q3
$8.36M Buy
89,570
+616
+0.7% +$59.6K 0.17% 96
2015
Q2
$8.67M Buy
88,954
+2,475
+3% +$248K 0.15% 98
2015
Q1
$8.7M Sell
86,479
-547,884
-86% -$55.7M 0.16% 101
2014
Q4
$66.3M Buy
634,363
+647
+0.1% +$68.2K 1.24% 28
2014
Q3
$67.5M Buy
633,716
+4,050
+0.6% +$420K 1.27% 23
2014
Q2
$65.9M Buy
629,666
+325,790
+107% +$32.9M 1.2% 20
2014
Q1
$29.9M Buy
303,876
+241,309
+386% +$22.4M 0.55% 68
2013
Q4
$5.73M Buy
62,567
+822
+1% +$75.8K 0.11% 105
2013
Q3
$5.35M Sell
61,745
-3,737
-6% -$335K 0.11% 112
2013
Q2
$5.62M Buy
+65,482
New +$5.56M 0.13% 104

Other funds holding JNJ

Geneva Advisors's JNJ Position: Q2 2017 in Review

Geneva Advisors reduced its Johnson & Johnson (JNJ) stake by 1.5% in Q2 2017, selling an estimated $246K and leaving 125,051 shares worth $16.5M. The position accounts for 0.28% of the portfolio, ranked #75.

Geneva Advisors first reported a position in JNJ in Q2 2013 and has held it in 17 quarters since. The position peaked at $67.5M in Q3 2014. 2,350 funds tracked by Wall St. Rank hold JNJ as of Q2 2017.

  • Geneva Advisors held 125,051 shares of Johnson & Johnson worth $16.5M as of Q2 2017.
  • Geneva Advisors sold 1,925 Johnson & Johnson shares in Q2 2017, an estimated $246K.
  • Johnson & Johnson made up 0.28% of Geneva Advisors's portfolio in Q2 2017, its #75 holding.
  • Geneva Advisors first reported a position in Johnson & Johnson in Q2 2013 and has held it in 17 quarters since.
  • Geneva Advisors's Johnson & Johnson position peaked at $67.5M in Q3 2014.
  • 2,350 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2017.

Based on Geneva Advisors's 13F filing for Q2 2017, filed 7 Aug 2017.